跳至主要内容
临床试验/NCT05564637
NCT05564637已完成2 期

Comprehensive O2 Transfer Analysis From the Lung to Mitochondria of Inhaled Treprostinil in Interstitial Lung Disease Pulmonary Hypertension

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2023年3月13日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
发起方
Mayo Clinic
入组人数
29
试验地点
1
主要终点
Cardiac Output Reserve (Qc)

研究概览

简要总结

The purpose of this research study is to find out more about the drug treprostinil via inhaler and the mechanisms of why patients with pulmonary arterial hypertension related to Interstitial Lung disease (PAH-ILD) have limitations during exercise. The investigator is studying treprostinil's effect on patients with PAH-ILD during exercise and its effect on their quality of life after using it for 3 months.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Pulmonary Arterial Hypertension due to Interstitial Lung Disease (ILD-PAH) being considered for inhaled treprostinil
  • Resting right heart catheterization with mean pulmonary artery pressure >20 mmHg and PVR> 3 Wood units
  • Healthy volunteers will have no known lung disease, heart failure, muscular disease or pulmonary hypertension, no bleeding abnormalities, and have the ability to exercise.

排除标准

  • Inability to exercise
  • Females who are pregnant

研究组 & 干预措施

Healthy Volunteers

Other

Healthy volunteers will undergo RHC while exercising and an optional muscle biopsy.

干预措施: Right Heart Catheterization (RHC) while exercising (Diagnostic Test)

Healthy Volunteers

Other

Healthy volunteers will undergo RHC while exercising and an optional muscle biopsy.

干预措施: Optional Muscle Biopsy (Diagnostic Test)

PAH-ILD Patients

Experimental

Patients diagnosed with PAH-ILD will undergo RHC while exercising, receive inhaled treprostinil, and undergo an optional muscle biopsy.

干预措施: Treprostinil (Drug)

PAH-ILD Patients

Experimental

Patients diagnosed with PAH-ILD will undergo RHC while exercising, receive inhaled treprostinil, and undergo an optional muscle biopsy.

干预措施: Right Heart Catheterization (RHC) while exercising (Diagnostic Test)

PAH-ILD Patients

Experimental

Patients diagnosed with PAH-ILD will undergo RHC while exercising, receive inhaled treprostinil, and undergo an optional muscle biopsy.

干预措施: Optional Muscle Biopsy (Diagnostic Test)

结局指标

主要结局

Cardiac Output Reserve (Qc)

时间窗: Baseline, approximately 35 minutes

Cardiac output reserve (Qc) is the difference between the heart's maximum output during exercise and its resting output. This was measured using the direct Fick method (L/min).

次要结局

  • Ventilatory Efficiency (VE/VCO2)(Baseline, approximately 35 minutes)
  • Resting Pulmonary Vascular Resistance(Baseline; after 30 minutes of rest)
  • Exercise Pulmonary Vascular Resistance(Baseline; approximately 35 minutes)
  • Resting Pulmonary Artery Pressure(Baseline; after 30 minutes of rest)
  • New York Heart Association (NYHA) Functional Class(Baseline, 3-months)
  • Exercise Pulmonary Artery Pressure(Baseline; approximately 35 minutes)
  • Resting Right Atrial Pressure(Baseline; after 30 minutes of rest)
  • Exercise Right Atrial Pressure(Baseline; approximately 35 minutes)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yogesh Reddy

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验